You are here
National Hospital Cost Data Collection, Reporting of work-in-progress, long stay patients and escalation factors, Round 18 (Financial year 2013-14)8 December 2015
The non-admitted study was comprehensive across a range of settings (e.g. outpatients, community and satellite clinics). Similarly all service streams were included regardless of funding source. This ensured that all services were accounted for and costed appropriately providing an accurate cost of delivering multiple services across multiple settings (e.g. overhead costs are apportioned across all patients).
National Hospital Cost Data Collection, Overnight Private Hospitals Cost Report, Round 17 (Financial year 2012-13)17 December 2014
The private sector National Hospital Cost Data Collection (NHCDC) is a voluntary collection that produces a range of hospital cost and activity information by Australian Refined Diagnosis Related Groups (AR-DRG).
The costing study on home delivered dialysis was undertaken in 2014. The purpose of the study was to collate and compare the range of costing studies and economic evaluations that have been carried out on these services over the past decade.
The report identifies two key studies - NSW Dialysis Costing Study, conducted in 2008, and Queensland Health Renal Replacement Therapy Costing Study, conducted in 2008 - which are useful in estimating the current costs of home-based dialysis.
PwC and its sub-contractor The Independent Hospital Pricing Authority (IHPA) engaged PwC and its sub-contractor SyRis Consulting to undertake a review and costing study of Australian radiotherapy services. The study was commissioned to determine the reliability of radiotherapy cost data due to its role in the development of associated price weights in both admitted and non-admitted settings.
National Hospital Cost Data Collection, Data Request Specifications, Round 18 (Financial year 2013-14)29 August 2014
The National Hospital Cost Data Collection (NHCDC) Data Request Specifications (DRS) list the data elements to be submitted to IHPA and include the validation rules which will be applied to the data on submission.
The NHCDC Strategic Review has been commissioned by the Independent Hospital Pricing Authority (IHPA) to assess the NHCDC's suitability as the primary data collection to determine the NEP, seek the views of stakeholders regarding issues with the current NHCDC and its future directions, and recommend a roadmap for the future. This review involved national consultation with 148 stakeholders, to examine positive and negative aspects of the NHCDC through interview and submission.
The Independent Hospital Pricing Authority (Pricing Authority) is established under the National Health Reform Act 2011 (Cth) (the Act), and by virtue of section 131(1) of the Act is invested with the following functions relevant to this National Efficient Price Determination 2014 (Determination):
(a) to determine the national efficient price for health care services provided by public hospitals where the services are funded on an activity basis;